Trials / Completed
CompletedNCT02244320
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
Observational Study in Patients With Functional BPH (Benign Prostatic Hyperplasia) Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,150 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the observational study were to investigate the switch from phytotherapy to ALNA® after at least 4 weeks of phytotherapy and still presented with a symptom sum score of ≥ 8 points (International Prostate Symptom Score (IPSS))
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamsulosin |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2003-05-01
- First posted
- 2014-09-19
- Last updated
- 2014-09-19
Source: ClinicalTrials.gov record NCT02244320. Inclusion in this directory is not an endorsement.